A closer look at the three core building blocks that give cholecyst-derived matrix its regenerative properties
Introduction
Nearly every property that makes an ECM scaffold clinically useful — its strength, its flexibility, its ability to signal cells and hold onto growth factors — traces back to three families of molecules: collagen, elastin, and glycosaminoglycans (GAGs). Cholecyst-derived ECM has been studied specifically for how these three components are arranged and preserved, and each plays a distinct, complementary role in the scaffold’s performance.
Collagen: The Structural Backbone
Collagen is the dominant structural protein in any ECM, and it is the primary component researchers isolate when they delaminate the collagen-rich matrix from the cholecyst wall. As in most connective tissues, Type I collagen — the most abundant collagen type generally found in mammalian tissue — provides the bulk of the scaffold’s tensile strength, while Type III collagen, which is typically associated with Type I in tissue matrices, contributes to the matrix’s early-stage flexibility and its ability to support rapid cell ingrowth. Together, these fibrillar collagens form the mesh-like network that gives cholecyst-derived ECM its mechanical integrity and its capacity to be sutured and handled surgically.
Elastin: The Matrix’s Elastic Memory
Woven through the collagen network is elastin, identified in structural studies of cholecyst ECM as interwoven within the same three-dimensional mesh architecture found across both tissue surfaces. Elastin is what allows a scaffold to stretch and recoil with the tissue it is repairing, rather than behaving as a rigid, inflexible patch. In skin and soft tissue applications, this elasticity is not a cosmetic detail — it directly affects how well a graft integrates with the natural movement of the surrounding tissue during healing.
Glycosaminoglycans: The Matrix’s Signal Reservoir
GAGs are the least visible but functionally critical component. In ECM generally, glycosaminoglycan molecules bind growth factors and cytokines and regulate water retention within the matrix — meaning they act as a controlled-release reservoir for the signaling molecules that drive cell migration, proliferation, and angiogenesis. A matrix that retains its native GAG content, rather than losing it during harsh chemical processing, is better positioned to actively participate in wound healing rather than simply serving as a passive collagen scaffold.
Why Processing Determines What Survives
All three of these components are vulnerable to loss during scaffold manufacturing, which is why processing method is such a heavily studied variable in cholecyst ECM research. Work from the SCTIMST group found that biomolecule retention was maximized, and unwanted tissue autodigestion minimized, using a controlled stabilization step during isolation — while excess cross-linking was shown to make biomolecules unavailable and reduce the scaffold’s bioinductive properties. The clear implication: collagen, elastin, and GAGs are only useful to a healing wound if the manufacturing process actually preserves them.
How CholeDerm® Preserves This Composition
CholeDerm® is manufactured through Alicorn Medical’s enzyme-free, detergent-free PrisTINE Process specifically to protect this molecular composition, retaining 154 biomolecules relevant to wound healing rather than relying on a stripped-down, collagen-only matrix. The result is a scaffold where collagen provides the structural framework, elastin supports natural flexibility, and GAGs continue to do the biochemical signaling work that a healing wound depends on.
Conclusion
Collagen, elastin, and GAGs are not interchangeable components — each does a job the others cannot. A scaffold that keeps all three intact, in a natural ratio and arrangement, gives a wound far more than a covering: it gives it the structural and biochemical toolkit to actually regenerate. That is the composition CholeDerm® is designed to deliver.